
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 3 - Jul 8
For Your Every Summer RSVP, with Code: SUMMER15
Description
Retatrutide for weight loss: Study shows 30% body weight loss UCHealth Today Follow me, then comment GLP1 below and I'll DM you our FREE Menopause & GLP 1s Cheat Sheet If you work with women in midlife, GLP 1 and GIP receptor agonists aren't Weight loss using GLP 1 drugs such as semaglutide (Ozempic) can cause huge muscle loss Rapid weight loss can cause a greater loss of muscle mass than losing weight slowly. Low muscle GLP1 RAs: The New Era of Diabetes and Weight Loss Management, FAQs in Pregnancy and Lactation
Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.5 ★★★★★
Based on 2292 reviews
Sort
Product Reviews
★★★★★ 5
Great for summer
Size: 5X-Large Big Tall, Color: Olive Green
Fits great, very light flowy material, one of the most comfortable shirts I own. I’ll be buying more colors
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 25, 2026
★★★★★ 3
Sizes differ
Size: 3X-Large Big Tall, Color: Pink
Sizes differ from each style shirt. A 3X in one style does not fit the same as a 3X from a different style even though it is the same company. The ones that I could find that fit were a nice shirt and comfortable. I would not rule out COOFANDY after trying one style shirt. To be honest I can’t remember if I kept this shirt or returned it but the return policy allows you to try different shirts so well worth the money to give it a shot. I needed a pink shirt to match my wife’s dress so I tried a couple different ones and ended up with a couple nice shirts at a reasonable price.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 23, 2026
★★★★★ 5
Buy lots of them!
Size: X-Large Big Tall, Color: Blue
My husband is big and tall, he wears XXL, these shirts are long enough for his waist, wide enough for his shoulders. They are very soft. They wear well. If you leave them in the dryer too long, it is easy to get the wrinkles out. Mist it with water and throw them back in and Wal-La no wrinkles. Love these shirts. Very well made.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 14, 2026
★★★★★ 5
True to size and great design
Color: White, Size: X-Large
I loved the shirt. It was sized to fit my body type. Not to big, not to small. The design is amazing.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on March 17, 2026
★★★★★ 5
Watch size!!!👍
Color: Gold Yellow, Size: XX-Large, Color: Gold Yellow, Size: XX-Large
Well, right outta the bag it fits Perfectly!!! I love it what more could I say? Very delighted!!! I can even button the top button😧😮🤪🤜🤛👏👏👏👏👏
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 25, 2026
recommand products
Semaglutide: What we know about safety and cancer risk
27.60
Semaglutide decelerates the growth and progression of breast cancer by enhancing the acquired antitumor immunity
23.65
GLP-1 medications may offer benefits beyond weight loss and diabetes management, including improved outcomes for breast cancer patients who are obese or have type 2 diabetes, according to new research. The study
22.40
Popular obesity medications significantly lower overall cancer risk, study finds. The breakthrough class of obesity medications, including GLP-1 receptor agonists like semaglutide and dual GLP-1/GIP receptor agonists like tirzepatide, continue to make
27.37
For years, researchers have known that obesity is associated with an increased risk of developing and dying from several cancers, including breast cancer. At ASCO 2026, new studies examining GLP-1 receptor agonists
28.96